Informa helps businesses and professionals in hundreds of ways.

Our international portfolio of live events, world-leading research publications, and innovative digital services provide specialists with the knowledge and connections they need to thrive.

TIDES USA: Oligonucleotide & Peptide Therapeutics
April 26-29, 2027
Hynes Convention CenterBoston, MA
Menu

Mark Neil Tolentino, PhD
Senior Scientist at Alnlyam Pharmaceuticals Inc.
Speaker

Profile

Dr. Mark Tolentino obtained his bachelors degree in Chemistry from University of Philippines in 2014. He received his PhD in Chemistry from the University of Connecticut in 2021 under the mentorship of Prof. Jessica L. Rouge. His graduate work focused on the development of stimuli-responsive nanoparticles by combining soft and inorganic materials for oligonucleotide and protein delivery applications. His current role at Alnylam involves developing new bio conjugation reactions for delivery of synthetic oligonucleotides for extra-hepatic delivery.

Agenda Sessions

  • Delivering RNAi to Extra-hepatic Tissues

    , 11:15am
    View Session

At this event

Prev
Next
Adam Oxley, PhD
Deputy Vice President of Membranes and Purification
Exactmer

See Mark Neil at TIDES USA: Oligonucleotide & Peptide Therapeutics